Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tumor-infiltrating lymphocyte immunotherapy for multiple metastatic cancers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Neuroendocrine Tumor
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Tumor-infiltrating lymphocyte (TIL) immunotherapy (tumor-infiltrating lymphocytes)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer | Phase 2 | Status: RECRUITING